PI-LAB-2025-191

Liraglutide, Independent Lab Report

Liraglutide 18mg · Cardinal Metabolic Clinic

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.8% met the stated ≥98% claim. Content measured 98.4% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.8%

Label claimed ≥98%

Content accuracy
98.4%

17.72mg measured against 18mg claimed

Test recency
Older result

Published 14 months ago

Specimen PI-LAB-2025-191 Tested by Axiom Mass Spec Services 10 samples tested from this company Purity & Testing score 98/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.8% Within analytical tolerance
Identity (MS) Liraglutide Confirmed Matches label
Content 18 mg 17.72 mg Within 5% of label

Methodology & chain of custody

HPLC-UV purity, ESI-MS identity, and Karl Fischer water content.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
A3293-25
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2025-191-report.pdf (document delivery arrives with the production storage backend)

More Tests, Cardinal Metabolic Clinic

Orforglipron
Purity 98.6% Verified
Retatrutide
Purity 93.7% Verified
Tirzepatide
Purity 99.2% Verified

More Tests, Liraglutide

Liraglutide Quantum Peptide Group
Purity 97.6% Verified
Liraglutide NextGen Peptides
Purity 97.3% Verified
Liraglutide Helix Research Supply
Purity 97.7% Verified